Erickson CM, Langlois CM, Wood EM, Mim R, Howe S, Ofidis D, Egleston BL, Harkins K, Largent EA, Roberts JS, Reiman EM, Denkinger M, Ashton NJ, Karlawish J, Bradbury AR, Langbaum JB. Evaluation of self-mediated alternatives for risk testing education and return of results (eSMARTER) study: A randomized study of methods for returning APOE and pTau-217 results , Alzheimers Dement (N Y), 11: 2025,e70177

Cocchella G, Phung L, Wood E, Egleston B, Hoffman-Andrews L, Brown S, Ofidis D, Mim R, Griffin H, Fetzer D, Owens A, Domchek S, Pyeritz R, Katona BW, Kallish S, Sirugo G, Weaver J, Nathanson KL, Rader DJ, Bradbury AR. An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobank , Eur J Med Genet, 78: 2025,105061

Henderson TO, Egleston B, Howe S, Allen MA, Mim R, Fleisher LG, Elkin EB, Oeffinger KC, Krull KR, Ofidis D, Mcleod B, Griffin H, Wood EM, Cacioppo CN, Brown S, Perpich M, Armstrong GT, Bradbury AR. The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer Survivors , medRxiv: 2025

Chavez-Yenter D, Fetzer D, Egleston B, Domchek S, Fleisher L, Wagner LI, Wen KY, Karpink K, Gutstein L, Posen S, Selmani E, McLeod B, Anantharajah A, Brown S, Cacioppo C, Cappadocia J, Ebrahimzadeh JE, Falcone D, Howe S, Langer C, McCarthy-Wood B, Weinberg M, Bradbury AR. The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing , BMC Cancer, 25: 2025,1642

Lee KT, McLeod B, Egleston B, Brown S, Howe S, Fetzer D, Gutstein L, Cacioppo C, Clark D, Domchek SM, Ebrahimzadeh J, Falcone D, Ofidis D, Griffin H, Mim R, Hernandez S, Fleisher L, Karpink K, Selmani E, Tahsin A, Wagner L, Weinberg M, Yi-Wen K, Wood E, Bradbury AR. An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial , JMIR Res Protoc, 14: 2025,e72515

Kimberley T. Lee, Carley Geiss, Hayden J. Fulton, Dannelle Charles, Brian D. Gonzalez, Heather S.L. Jim, N. Lynn Henry, Dawn L. Hershman, Shelley S. Tworoger, Angela Bradbury, Oluwadamilola M. Fayanju, Susan T. Vadaparampil and Clement K. Gwede Hidden Costs of Endocrine Therapy for Black Breast Cancer Survivors: A Qualitative Examination of Patient and Provider Experiences , Clinical Breast Cancer: 2025

Trieu P, Fetzer D, McLeod B, Schweickert K, Gutstein L, Egleston B, Domchek S, Fleisher L, Wagner L, Wen KY, Cacioppo C, Ebrahimzadeh JE, Falcone D, Langer C, Wood E, Karpink K, Posen S, Selmani E, Bradbury AR. Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study , JMIR Form Res, 9: 2025,e56282

Demarest K, Anantharajah A, Maxwell KN, Rohanizadegan M, Bradbury A, Nathanson KL, McCarthy AM, Domchek SM, Nayak A, Shah PD. Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer , JAMA Netw Open, 8: 2025,e2460312

Snyder GG, Clay D, Karley S, Pipito S, Mueller R, Bradbury A, Maxwell K, Nathanson KL, Rohanizadegan M, Shah P, Domchek SM, Long JM, Katona BW. Assessment of barriers to pancreatic cancer surveillance in high-risk individuals , J Genet Couns: 2025

Kilbride MK, Chavez-Yenter D, Wong B, Roberts JS, Park J, Iuliano J, Bradbury AR. Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk , Am J Med Genet A: 2025